Gilead Sciences has granted non-exclusive, royalty-free licenses to six generic manufacturers to produce and distribute lenacapavir in 120 low-income...

ImmunoPrecise Antibodies and Biotheus have collaborated to develop bispecific therapies for solid tumors. Biotheus will evaluate Talem Therapeutics’ AI-enhanced...

Owkin and AstraZeneca are collaborating on an AI-powered tool that will pre-screen for harmful mutations in breast cancer genes...

Blue Earth Diagnostics, a renowned company in PET radiopharmaceutical development, announced the results of a post-hoc analysis from the...

Maze Therapeutics, a biopharmaceutical company, has commenced its Phase 1 clinical trial for MZE782, an oral small molecule therapy....

ONYDA XR (clonidine hydrochloride), a groundbreaking liquid non-stimulant ADHD medication, has been released for commercial availability in the United...

Merck has acquired CN201, a bispecific antibody, from Curon Biopharmaceutical. This acquisition strengthens Merck’s pipeline for treating B-cell malignancies...

Daiichi Sankyo and AstraZeneca‘s application for ENHERTU has been accepted for Priority Review by the US Food and Drug...

In the rapidly evolving landscape of health data regulation, the European Health Data Space (EHDS) initiative marks a transformative...

Fresenius Kabi, a subsidiary of Fresenius, and Formycon AG, a leading biosimilars developer, have received FDA approval for Otulfi™...